NS

Naveed Siddiqi

Senior Partner, Novo Holdings

United Kingdom

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Senior Partner

    2021

    Naveed is a member of Ventures Investment leadership team. Naveed is also a member of the Investment Committee for Novo Holdings Asia PTE.

  • Partner

    2019

    Novo Holdings is a company wholly owned by the Novo Nordisk Foundation. It is the holding and investment company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Novo Nordisk Foundation’s assets. Novo Holdings is recognized as a one of the world's largest international life science investors, with a focus on creating long- term value. Novo Holdings provides seed and venture capital to development- stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings manages $13 billion of life science investments.

  • Board Member

    2024

  • Board Member

    2023

  • Board Observer

    2021

  • LP Advisory Committee Member

    2021

2020

  • Board Member

    2020

2020 - 2024

  • Board Member

    2020 - 2024

2021 - 2022

  • Board Member

    2021 - 2022

2020 - 2021

  • Board Member

    2020 - 2021

2013 - 2018

  • Partner

    2013 - 2018

    Partner - life sciences at Andera Partners (formerly Edmond de Rothschild Investment Partners). The life sciences team of Andera Partners is a highly experienced and leading investor in therapeutic and medical technology companies. Andera Partners has over €2bn under management across European growth equity and global life sciences.